4-氨基-1-BETA-D-呋喃核糖基-1H-咪唑并[4,5-C]吡啶合成路线 (共 17 条)
反应条件
1.1: imidazole / dimethylformamide / 20 h / 20 °C 2.1: 3.52 g / K2CO3 / dimethylformamide / 2.5 h / 80 °C 3.1: 70 percent / ethylenediamine / 6 h / 50 °C 4.1: 95 percent / p-toluenesulfonyl chloride; pyridine / 20 h / 20 °C 5.1: 60 percent / diiodomethane; isoamyl nitrite / 0.75 h / 100 °C 6.1: Pd(PhCN)2Cl2; Et3N / acetonitrile / 20 h / 110 °C 6.2: 50 percent / NH3; methanol / 14 h / 120 °C 7.1: 79 percent / Amberlite IRA 900 fluoride-form / toluene / 6 h / Heating View Scheme
参考文献
Journal of the American Chemical Society, , vol. 128, # 13 p. 4453 - 4459
反应条件
1.1: 95 percent / p-toluenesulfonyl chloride; pyridine / 20 h / 20 °C 2.1: 60 percent / diiodomethane; isoamyl nitrite / 0.75 h / 100 °C 3.1: Pd(PhCN)2Cl2; Et3N / acetonitrile / 20 h / 110 °C 3.2: 50 percent / NH3; methanol / 14 h / 120 °C 4.1: 79 percent / Amberlite IRA 900 fluoride-form / toluene / 6 h / Heating View Scheme
参考文献
Journal of the American Chemical Society, , vol. 128, # 13 p. 4453 - 4459
反应条件
1: lithium azide / dimethylformamide / 18 h / 120 °C 2: 6N aq. HCl, H2 / 10percent Pd/C / 36 h / 2068.6 Torr 3: 79 percent / K2HPO4 / H2O / 72 h / 37 °C / uridine phosphorylase, purine nucleoside phosphorylase View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 29, # 1 p. 138 - 143
反应条件
1: 6N aq. HCl, H2 / 10percent Pd/C / 36 h / 2068.6 Torr 2: 79 percent / K2HPO4 / H2O / 72 h / 37 °C / uridine phosphorylase, purine nucleoside phosphorylase View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 29, # 1 p. 138 - 143
反应条件
1: 83 percent / imidazole / dimethylformamide / Ambient temperature 2: 76 percent / ammonia / methanol / 3 h / 120 °C 3: tetrabutylammonium fluoride / tetrahydrofuran View Scheme
参考文献
Tetrahedron Letters, , vol. 34, # 4 p. 661 - 664
反应条件
1: 76 percent / ammonia / methanol / 3 h / 120 °C 2: tetrabutylammonium fluoride / tetrahydrofuran View Scheme
参考文献
Tetrahedron Letters, , vol. 34, # 4 p. 661 - 664
反应条件
pyridine; 1,8-diazabicyclo[5.4.0]undec-7-ene T=20°C; 2 h;
参考文献
Bioorganic and Medicinal Chemistry, , vol. 12, # 13 p. 3637 - 3647